Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2022-10-01
2025-01-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
At this time the investigators however do not know very much about how well insect protein compares to animal protein as a nutritious food source. This research project is therefore one of the first to compare some of the nutritional properties between animal and insect proteins.
In brief, this study involves eating a sweet breakfast muffin made of either whey (animal) protein powder or cricket flour (very finely ground whole adult crickets) and then breathing into test tubes at various time points for a few hours as well as collecting some small amounts of blood using a finger stick to measure blood glucose and fats.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perceived Satiety and Consumer Sensory Acceptance of Functional Foods Enriched With Edible Insect and Plant Proteins
NCT07181408
How Cricket Powder Affects Gut Microbiome and Cholesterol Metabolism
NCT07009756
OAT-GUT-BRAIN: Effects of Oats and Rice on Comprehensive Health of Metabolically Challenged Individuals
NCT05526092
Impact of Protein Content of Ultraprocessed Foods on the Regulation of Energy Balance
NCT05337007
Effects of Barley Based Food Products on Metabolism and Gut Microflora
NCT02427555
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A slower GE rate is particularly important regarding postprandial plasma triacylglycerol concentrations, with impaired clearance being related to inflammation and cardiovascular disease. The attenuation of the postprandial increase in blood glucose has long been a goal for improved metabolic health. As reviewed, small differences in GE can have a major impact on postprandial glycaemia in health and type 2 diabetes (2.). Furthermore, a slowed gastric emptying rate as a result of certain types of food is associated with a delayed reoccurrence of feeling of hunger and can influence satiation.
The 13C octanoic acid breath test is a relatively cheap, non-invasive, and simple test to measure GE. The test is performed via the ingestion of a controlled meal containing the commercially available non-harmful stable isotope 13C in a short chain fatty acid (C8) and the following detection of the 13Clabelled CO2 in the breath (3.).
The data generated by the breath test is commonly analysed with a one compartment model based on Ghoos et al (1993) (4.) to generate parameters such as half time and lag time. More advanced semi mechanistic models are used in pharmacokinetics and could be applied to the breath test.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Whey Protein intervention
Cricket Protein
Participants are provided with muffins containing either whey or cricket protein.
Insect
Cricket Protein intervention
Cricket Protein
Participants are provided with muffins containing either whey or cricket protein.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cricket Protein
Participants are provided with muffins containing either whey or cricket protein.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI between 18.5 and 35 kg/m2
* Weight stable for 3 months (± 2 kg)
* Volunteers must be able and willing to give informed written consent
* Volunteers must be able to eat egg (because egg is required for preparation of the stable isotope dosage see section experimental design).
Exclusion Criteria
* Those taking (or have been taking within the past 6 months) regular medication, excluding contraceptive medication, or food supplements (e.g., vitamins, minerals, fish oil, fibre supplements, antioxidant tablets) - assessed via a health questionnaire (appendix) Those smoking, using nicotine products (e.g., e-cigarettes, patches) or not abstained from these activities for more than 6 months
* Pregnant or lactating
* Volunteers with a habitual caffeine intake \> 300 mg/day (more than 5 cups standard coffee)
* Drug or alcohol abuse in the last 2 years
* The principal investigator considers it unsafe / unsuitable for the volunteer to be in the study
* Those who are currently taking part in a clinical trial or another research study or have taken part within the last 3 months
* Those who do not refrain from alcohol, caffeine containing drinks (e.g., coffee, coca cola, tea, Red Bull) and strenuous exercise 10 hours before the laboratory session
* Those with food allergies, dietary intolerance (especially for egg), or Coeliac disease
* Those following weight reducing diets
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Surrey
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Surrey
Guildford, Surrey, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FHMS 21-22 231 EGA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.